Table 2. Participating caregivers’ (N=66) access to
allergy-related care, including type of delivery, during the COVID-19
pandemic
Type of care |
|
|
Satisfaction |
Satisfaction |
|
n |
% |
mean |
SD |
A. Allergy-related care* |
|
|
|
|
Initial assessment |
22 |
33.3 |
72.5 |
24.4 |
Follow-up |
50 |
75.8 |
78.0 |
27.2 |
Early introduction |
3 |
4.5 |
89.3 |
9.5 |
Oral food challenge |
18 |
27.3 |
77.9 |
27.3 |
Oral immunotherapy |
14 |
21.2 |
87.4 |
26.4 |
B. Allergy-related care by type of delivery |
B.
Allergy-related care by type of delivery |
B. Allergy-related
care by type of delivery |
|
|
Initial assessment |
|
|
|
|
Virtual |
12 |
54.5 |
66.5 |
27.6 |
In-person |
7 |
31.9 |
81.1 |
14.2 |
Both |
3 |
13.6 |
76.3 |
30.7 |
Follow-up |
|
|
|
|
Virtual |
35 |
70.0 |
75.2 |
29.6 |
In-person |
14 |
28.0 |
83.6 |
20.3 |
Both |
1 |
2.0 |
97.0 |
- |
Early introduction |
|
|
|
|
Virtual |
3 |
100.0 |
89.3 |
9.5 |
In-person |
0 |
0.0 |
- |
- |
Both |
0 |
0.0 |
- |
- |
Oral food challenge |
|
|
|
|
Virtual |
16 |
88.9 |
76.0 |
28.5 |
In-person |
0 |
0.0 |
- |
|
Both |
2 |
11.1 |
93.0 |
1.4 |
Oral immunotherapy |
|
|
|
|
Virtual |
8 |
57.1 |
91.5 |
9.8 |
In-person |
0 |
0.0 |
0.0 |
0.0 |
Both |
6 |
42.9 |
82.0 |
40.2 |
Not mutually exclusive |
|
|
|
|
Abbreviation: SD Standard deviation |
Abbreviation: SD
Standard deviation |
Abbreviation: SD Standard deviation |
|
|